Dr. Jonathan Zager, MD

• General Surgery

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Montefiore Medical Center

  Residency Hospital, 2004

• Memorial Sloan Kettering Canc Center

  Fellowship Hospital, 2001

• N Shore University Hospital

  Internship Hospital, 1999

• Sackler School Of Medicine, Tel Aviv University

  Medical School, 1997

• The Role of Radical Amputations for Extremity Tumors: A Single Institution Experience and Review of the Literature, 2011-08-11

• Introduction: Novel Frontiers in Cancer Metastasis, 2022-02-22

• A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities, 2011-12-06

• Radiotherapy Influences Local Control in Patients With Desmoplastic Melanoma, 2013-10-18

• Chemoprevention Agents for Melanoma: A Path Forward into Phase III Clinical Trials, 2018-10-03

• Cutaneous Angiosarcoma: A Single-Institution Experience, 2013-07-09

• Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia, 2020-09-11

• Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease, 2017-12-28

• Treatment of Head and Neck Melanoma in Situ with Staged Contoured Marginal Excisions, 2016-10-27

• Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion, 2011-10-07

• Molecular Aspects of the Isolated Limb Infusion Procedure, 2021-02-07

• Single cell characterization of the cellular landscape of acral melanoma identifies novel targets for immunotherapy, 2022-05-13

• Percutaneous Hepatic Perfusion with Melphalan for Unresectable Metastatic Melanoma or Sarcoma to the Liver: A Single Institution Experience, 2013-11-19

• Surveillance of sentinel node positive melanoma patients who receive adjuvant therapy without undergoing completion lymph node dissection, 2021-08-06

• A Collision of Diseases: Chronic Lymphocytic Leukemia Discovered During Lymph Node Biopsy for Melanoma, 2012-11-20

• Sentinel node biopsy is indicated for thin melanomas =0.76 mm, 2012-07-06

• Robotic-assisted Trans-peritoneal Pelvic Lymphadenectomy For Metastatic Melanoma: Early Outcomes Compared To Open Pelvic Lymphadenectomy, 2016-01-14

• Desmoplastic Melanoma: Is There a Role for Sentinel Lymph Node Biopsy?, 2013-02-07

• Single institution outcome experience using AlloDerm® as temporary coverage or definitive reconstruction for cutaneous and soft tissue malignancy defects, 2015-07-14

• Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial, 2016-06-24

• A Multi-Institution Experience Comparing the Clinical and Physiologic Differences between Upper Extremity and Lower Extremity Melphalan-Based Isolated Limb Infusion, 2012-06-06

• A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology, 2014-03-10

• Clinicopathologic Predictors of Survival in Patients with Desmoplastic Melanoma, 2015-03-26

• Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma, 2013-03-21

• Burden of Disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma, 2014-09-06

• Isolated Limb Infusion in a Series of over 100 Infusions, a Single Center Experience, 2013-03-02

• Surgeon Decision-Making for Management of Positive Sentinel Lymph Nodes in the Post-Multicenter Selective Lymphadenectomy Trial II Era: A Survey Study, 2020-12-01

• Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma, 2020-12-18

• Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?, 2016-03-08

• The Unique Clinical Characteristics of Melanoma Diagnosed in Children, 2012-08-03

• The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma, 2017-02-21

• A Multi-center Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-arterial Temozolomide for Patients with Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion, 2014-08-22

• Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience, 2015-10-15

• International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node Positive Melanoma, 2022-01-27

• Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma, 2017-02-15

• Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients, 2018-02-05

• A Multicenter Prospective Evaluation of the Clinical Utility of F-18 FDG-PET/CT in Patients With AJCC Stage IIIB or IIIC Extremity Melanoma, 2015-10-18

• Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?, 2018-10-11

• Editorial: Novel Frontiers in Cancer Metastasis, 2022-02-12

• Isolated Limb Infusion: A Single-Center Experience with Over 200 Infusions, 2017-10-10

• Sentinel Lymph Node Biopsy Is Indicated for Patients With Thick Clinically Lymph Node-Negative Melanoma, 2015-02-11

• Active Surveillance of Patients Who Have Sentinel Node Positive Melanoma: An International, Multi-Institution Evaluation of Adoption and Early Outcomes After the Multicenter Selective Lymphadenectomy Trial II (MSLT-2), 2021-04-07

• Progression of cutaneous melanoma: implications for treatment, 2012-08-15

• Combined Analysis of Phase III Trials Evaluating [99mTc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma, 2012-10-03

• Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis, 2019-03-25

• Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma, 2020-12-19

• Talimogene Laherparepvec (TVEC) for the Treatment of Advanced Melanoma: A Single-Institution Experience, 2018-10-08

• Both Tumor Depth and Diameter Are Predictive of Sentinel Lymph Node Status and Survival in Merkel Cell Carcinoma, 2015-06-02

• Merkel Cell Carcinoma of Unknown Primary Origin, 2012-01-21

• Cutaneous Leiomyosarcoma: A Single Institution Experience of Treatment and Outcomes with a Standardized Margin of Resection, 2015-07-12

• Pediatric Melanoma: Analysis of an International Registry, 2013-09-10

• Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?, 2018-08-02

• Behavior of Cutaneous Adnexal Malignancies: A Single Institution Experience, 2018-06-14

• Isolated Limb Infusion for Limb Salvage in Limb Threatening Extremity Sarcomas, 2012-12-03

• Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of Progress, 2023-02-23

• Analysis of Tumor Mitotic Rate in Thin Metastatic Melanomas Compared With Thin Melanomas Without Metastasis Using Both the Hematoxylin and Eosin and Anti-phosphohistone 3 IHC Stain, 2018-01-06

• Four cases of disseminated herpes simplex virus following talimogene laherparepvec injections for unresectable metastatic melanoma, 2023-01-27

• Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma, 2018-03-02

• Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study, 2022-05-13

• Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies, 2017-10-12

• Future perspectives: Novel Frontiers in Cancer Metastasis, 2022-02-12

• Comparison of Single-Photon Emission Computed Tomography -Computed Tomography (SPECT/CT) and Conventional Planar Lymphoscintigraphy for Sentinel Node Localization in Patients with Cutaneous Malignancies, 2016-09-22

• Stratifying SLN incidence in intermediate thickness melanoma patients, 2017-12-14

• Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma, 2016-05-12